“FDA Proposes Reclassifying ECT Devices”

1
176

The Food and Drug Administration (FDA) is attempting to reclassify the electroconvulsive therapy (ECT) device for use in treating severe depression (MDE) or bipolar “disorder” (BPD). The device is currently a class III device and the proposal is to make it a class II device.

Article →

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time

1 COMMENT

  1. The FDA is lost and hasn’t a clue about half of the things they approve. They also haven’t figured out yet that there is no proof anywhere that “metal illness” regardless of how it’s defined benefits greatly from the psychiatric intervention.

    Let’s label this for what it is: a torture device. Used by the moral police (mental health in all it’s ineffective, greedy forms).

LEAVE A REPLY